RespiratoryInfectious Disease
Hospital-Acquired Pneumonia
NICE NG139 — early- vs late-onset, empirical antibiotics by severity + risk factors, escalation criteria.
Source: NICE NG139; ATS/IDSA 2016
Step 1 of ~5
info
Definition & Initial Assessment
HAP = pneumonia developing ≥48h after hospital admission, NOT incubating at admission. VAP = ≥48h after intubation. ABCDE; SpO₂; bloods (FBC, U&E, CRP, lactate, blood culture × 2 sets); CXR; sputum culture if obtainable; ABG if hypoxic. CURB-65 helps stratify but designed for community-acquired.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Lefamulin · Pleuromutilin Antibiotic (Community-Acquired Pneumonia)
- Ceftriaxone (Paediatric) · Third-Generation Cephalosporin — Meningitis / Sepsis / Community-Acquired Pneumonia
- Amoxicillin · Antibiotic — Community-Acquired Pneumonia
- Caplacizumab · Anti-vWF Nanobody — Acquired TTP
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- Acute Exacerbation of COPD (AECOPD) · NICE NG115; GOLD 2024
- Spontaneous Pneumothorax (Adult) · BTS Pleural Disease 2023
- Atypical Pneumonia (Legionella / Mycoplasma / Chlamydophila) · BTS 2023; IDSA
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
Decision support only. Always apply local guidelines and clinical judgement.